Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1996 Apr;50(2):174–177. doi: 10.1136/jech.50.2.174

Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.

P Sawanpanyalert 1, S Boonmar 1, T Maeda 1, Y Matsuura 1, T Miyamura 1
PMCID: PMC1060248  PMID: 8762384

Abstract

OBJECTIVE: The role of sexual transmission in hepatitis C virus (HCV) infection has not yet been completely elucidated. This study aimed to compare the risk factors for HCV and human immunodeficiency virus (HIV) infection in an HIV epidemic area of Thailand where HIV is mainly transmitted heterosexually. DESIGN AND SUBJECTS: Sera from 3053 blood donors were collected and tested for HCV and HIV between January and March 1994. Altogether 1756 (57.5%) of the donors were interviewed about demographics and several risk factors. RESULTS: The prevalence rates of HIV and HCV infections determined by antibody assays were 2.3% and 2.2%, respectively. Sexual risk factors were clearly shown among anti-HIV positive donors. These clear associations were not found, however, among anti-HCV positive donors. In contrast, previous histories of injecting drug use and being tattooed were found in some anti-HCV positive donors but less frequently in anti-HIV positive donors. CONCLUSIONS: Sexual transmission may play a relatively minor role in HCV transmission compared with HIV, in this area.

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdelaal M., Rowbottom D., Zawawi T., Scott T., Gilpin C. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia. Transfusion. 1994 Feb;34(2):135–137. doi: 10.1046/j.1537-2995.1994.34294143941.x. [DOI] [PubMed] [Google Scholar]
  2. Archer G. T., Buring M. L., Clark B., Ismay S. L., Kenrick K. G., Purusothaman K., Kaldor J. M., Bolton W. V., Wylie B. R. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust. 1992 Aug 17;157(4):225–227. doi: 10.5694/j.1326-5377.1992.tb137122.x. [DOI] [PubMed] [Google Scholar]
  3. Boonmar S., Pojanagaroon B., Watanabe Y., Tanaka Y., Saito I., Miyamura T. Prevalence of hepatitis C virus antibody among healthy blood donors and non-A, non-B hepatitis patients in Thailand. Jpn J Med Sci Biol. 1990 Apr;43(2):29–36. doi: 10.7883/yoken1952.43.29. [DOI] [PubMed] [Google Scholar]
  4. Darwish M. A., Raouf T. A., Rushdy P., Constantine N. T., Rao M. R., Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993 Oct;49(4):440–447. doi: 10.4269/ajtmh.1993.49.440. [DOI] [PubMed] [Google Scholar]
  5. Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
  6. Eyster M. E., Alter H. J., Aledort L. M., Quan S., Hatzakis A., Goedert J. J. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 1991 Nov 15;115(10):764–768. doi: 10.7326/0003-4819-115-10-764. [DOI] [PubMed] [Google Scholar]
  7. Janot C., Couroucé A. M., Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet. 1989 Sep 30;2(8666):796–797. doi: 10.1016/s0140-6736(89)90851-9. [DOI] [PubMed] [Google Scholar]
  8. Katayama T., Mazda T., Kikuchi S., Harada S., Matsuura Y., Chiba J., Ohba H., Saito I., Miyamura T. Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen. Hepatology. 1992 Mar;15(3):391–394. doi: 10.1002/hep.1840150306. [DOI] [PubMed] [Google Scholar]
  9. Lissen E., Alter H. J., Abad M. A., Torres Y., Pérez-Romero M., Leal M., Pineda J. A., Torronteras R., Sánchez-Quijano A. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis. 1993 Nov;12(11):827–831. doi: 10.1007/BF02000402. [DOI] [PubMed] [Google Scholar]
  10. McKenna J. G., Evans G., Lyttle P. H., Couper A. Hepatitis C virus seroprevalence in patients attending a sexual health centre. N Z Med J. 1994 Jan 26;107(970):8–10. [PubMed] [Google Scholar]
  11. Miyamura T., Saito I., Katayama T., Kikuchi S., Tateda A., Houghton M., Choo Q. L., Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A. 1990 Feb;87(3):983–987. doi: 10.1073/pnas.87.3.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Neal K. R., Jones D. A., Killey D., James V. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect. 1994 Jun;112(3):595–601. doi: 10.1017/s0950268800051293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nelson K. E., Celentano D. D., Suprasert S., Wright N., Eiumtrakul S., Tulvatana S., Matanasarawoot A., Akarasewi P., Kuntolbutra S., Romyen S. Risk factors for HIV infection among young adult men in northern Thailand. JAMA. 1993 Aug 25;270(8):955–960. [PubMed] [Google Scholar]
  14. Nopkesorn T., Mastro T. D., Sangkharomya S., Sweat M., Singharaj P., Limpakarnjanarat K., Gayle H. D., Weniger B. G. HIV-1 infection in young men in northern Thailand. AIDS. 1993 Sep;7(9):1233–1239. doi: 10.1097/00002030-199309000-00013. [DOI] [PubMed] [Google Scholar]
  15. Osmond D. H., Charlebois E., Sheppard H. W., Page K., Winkelstein W., Moss A. R., Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan;167(1):66–71. doi: 10.1093/infdis/167.1.66. [DOI] [PubMed] [Google Scholar]
  16. Patiño-Sarcinelli F., Hyman J., Camacho L. A., Linhares D. B., Azevedo J. G. Prevalence and risk factors for hepatitis C antibodies in volunteer blood donors in Brazil. Transfusion. 1994 Feb;34(2):138–141. doi: 10.1046/j.1537-2995.1994.34294143942.x. [DOI] [PubMed] [Google Scholar]
  17. Ranger S., Martin P., Roussanne M. C., Denis F. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France. Gut. 1993;34(2 Suppl):S50–S51. doi: 10.1136/gut.34.2_suppl.s50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Richards C., Holland P., Kuramoto K., Douville C., Randell R. Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion. 1991 Feb;31(2):109–113. doi: 10.1046/j.1537-2995.1991.31291142939.x. [DOI] [PubMed] [Google Scholar]
  19. Serfaty L., Giral P., Elghouzzi M. H., Jullien A. M., Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology. 1993 Feb;17(2):183–187. [PubMed] [Google Scholar]
  20. Stevens C. E., Taylor P. E., Pindyck J., Choo Q. L., Bradley D. W., Kuo G., Houghton M. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA. 1990 Jan 5;263(1):49–53. [PubMed] [Google Scholar]
  21. Takeuchi K., Boonmar S., Kubo Y., Katayama T., Harada H., Ohbayashi A., Choo Q. L., Kuo G., Houghton M., Saito I. Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis. Gene. 1990 Jul 16;91(2):287–291. doi: 10.1016/0378-1119(90)90102-w. [DOI] [PubMed] [Google Scholar]
  22. Takeuchi K., Kubo Y., Boonmar S., Watanabe Y., Katayama T., Choo Q. L., Kuo G., Houghton M., Saito I., Miyamura T. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol. 1990 Dec;71(Pt 12):3027–3033. doi: 10.1099/0022-1317-71-12-3027. [DOI] [PubMed] [Google Scholar]
  23. Thomas D. L., Cannon R. O., Shapiro C. N., Hook E. W., 3rd, Alter M. J., Quinn T. C. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis. 1994 May;169(5):990–995. doi: 10.1093/infdis/169.5.990. [DOI] [PubMed] [Google Scholar]
  24. Vanderborght B. O., Reis A. M., Rouzere C. D., da Silva R. S., Yoshida C. F., Franco L. G., Maertens G., Van Heuverswijn H., Moreira Pereira J. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro. Vox Sang. 1993;65(2):122–125. doi: 10.1111/j.1423-0410.1993.tb02128.x. [DOI] [PubMed] [Google Scholar]
  25. Weinstock H. S., Bolan G., Reingold A. L., Polish L. B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA. 1993 Jan 20;269(3):392–394. [PubMed] [Google Scholar]
  26. al-Nakib B., Koshy A., Kaloui M., al-Ramahi S., al-Mufti S., Radhakrishnan S., al-Nakib W. Hepatitis C virus antibody in Kuwait. Vox Sang. 1992;63(1):75–76. doi: 10.1111/j.1423-0410.1992.tb01224.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES